Naoki Tanaka
Matsumoto, 3908621, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 144 publications
Serum Metabolomics Reveals Carnitine Metabolism as a Possible Central Metabolic Axis of Pemafibrate Action.
Journal: International journal of molecular sciences
Published: May 13, 2026
Hepatocyte PPARα Is Essential for Triglyceride-Lowering Effect of Pemafibrate.
Journal: International journal of molecular sciences
Published: January 12, 2026
Editorial: Beyond Viral Eradication-Cardiometabolic Risk and Cardiovascular Outcomes After SVR in Chronic Hepatitis C.
Journal: Alimentary pharmacology & therapeutics
Published: December 26, 2025
Integrative Multi-Omics Analysis Identifies Stellate Cell-Derived Complement Component 7 as a Predictor of Fibrosis and Liver-Related Events in MASLD Patients.
Journal: JHEP reports : innovation in hepatology
Published: November 04, 2025
Guidance for Liver Rehabilitation in Chronic Liver Disease.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: September 02, 2025
Metabolic dysfunction-associated steatotic liver disease (MASLD): definition, diagnosis, natural history, and treatment.
Journal: Japanese journal of radiology
Published: August 01, 2025
Gastrointestinal Cancer Risk in Steatotic Liver Diseases: MASLD, MetALD and ALD.
Journal: Alimentary pharmacology & therapeutics
Published: July 25, 2025
Prognostic Significance of Bile Duct Loss in Early-Stage Primary Biliary Cholangitis: A Long-Term Observational Study.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: June 02, 2025
Kori-tofu ameliorates obesity and steatotic liver disease through enhancing GLP-1 production in the ileum.
Journal: International journal of biological macromolecules
Published: May 06, 2025
IgA-Enriched Phenotype Predicts Liver-Related Events in MASLD.
Journal: Journal of hepatology
Published: April 08, 2025
Last Updated: 09/26/2026